ABC World News Focuses on 'Sophisticated' Breast Cancer Screening (Diagnostic Test Known as Breast-Specific Gamma Imaging, or BSGI)

ABC World News Focuses on 'Sophisticated' Breast Cancer Screening (Diagnostic Test Known as Breast-Specific Gamma Imaging, or BSGI)

During Medicine on the Cutting Edge Segment, Physicians and Patients Discuss Positive Impact of BSGI Test 'Few Women Know About'

NEWPORT NEWS, Va., Oct. 24 /PRNewswire/ -- Last evening, ABC World News with Charles Gibson aired a Medicine on the Cutting Edge segment regarding an advanced breast cancer diagnostic test referred to in the story as Radioactive Imaging, but technically known as Breast-Specific Gamma Imaging, or BSGI. The story was preceded with Mr. Gibson commenting that mammograms, the primary form of breast cancer examination, "miss up to 20 percent of cancers."

The segment, reported by John McKensey, featured interviews and commentaries with notable physicians who have experience using BSGI. The specialists included breast radiologist Lillian Stern, M.D. of Methodist Hospital (Jefferson Hospital System) in Philadelphia. During the broadcast Dr. Stern, using BSGI with the Dilon 6800 Gamma Camera, diagnosed patient Barbara Hardy as cancer-free after an inconclusive mammogram.

Another patient featured in the story, Ines Fusco, previously had both a mammogram and ultrasound. Neither test showed any sign of cancer; however, Ms. Fusco pursued additional testing because she felt a small lump in her breast. As presented in the segment, Ms. Fusco was then tested with Breast-Specific Gamma Imaging (BSGI). From the BSGI results, her physician concluded that she did indeed have a lump, which was cancerous and subsequently treated. Regarding the BSGI test Ms. Fusco remarked, "I give it all the credit in the world. It saved my life."

About Breast-Specific Gamma Imaging

Breast-Specific Gamma Imaging (BSGI) with the Dilon 6800 Gamma Camera is a complementary diagnostic tool to detect breast cancer when post-mammogram evaluation is indicated. BSGI is able to detect early stage cancers, identify suspicious and difficult-to-interpret breast abnormalities, and help differentiate between benign and malignant tumors. Patients receive a small amount of a radiotracer agent via an injection in the arm that is absorbed by all cells in their body. Because cancerous cells have higher metabolic activity, they absorb a greater amount of the tracer and light up to reveal themselves as "hot spots" to the Dilon 6800.

About Dilon Technologies LLC

Dilon Technologies LLC is bringing innovative new medical products to the market based on research conducted at leading national research laboratories. Dilon's cornerstone product is the Dilon 6800 Gamma Camera -- a high- resolution, anatomic-specific gamma camera, which is now being used to perform Breast-Specific Gamma Imaging (BSGI), a molecular imaging technique that images the metabolic activity of breast lesions through radiotracer uptake. Several leading medial centers around the country are now offering BSGI to their patients, including: Beth Israel Medical Center, New York; George Washington University Medical Center, Washington, D.C.; Alexian Brothers Medical Center, Chicago; Breast Health Institute, Orlando; and West Valley Imaging, Las Vegas.

BSGI with the Dilon 6800 Gamma Camera will be a featured topic of discussion at ...

The Chicago International Breast Course
Symposium: Breast-Specific Gamma Imaging
Thursday, October 26 from 6:00 to 8:00PM
Grant/ Lincoln Room - River Level 1
The Westin Chicago River North
Speakers: Lillian Stern, M.D., Rachel Brem, M.D. and Jean Weigert, M.D.

BSGI with the Dilon 6800 Gamma Camera will be on display at ...
Radiological Society of North America (RSNA) 92nd Scientific Assembly and
Annual Meeting
November 26 - December 1, 2006
McCormick Place, Chicago, Ill.
North Building, Hall B - Booth #8707

For details about these events contact:
Nancy F. Morter,
Dilon Technologies LLC
C: 757-589-3914
O: 757-269-4910 x02
E: nfmorter@dilon.com

To find out more about BSGI or the Dilon 6800 Gamma Camera please visit http://www.dilon.com/ .

First Call Analyst:
FCMN Contact:

Source: Dilon Technologies LLC

CONTACT: Nancy F. Morter of Dilon Technologies LLC, cell,
+1-757-589-3914, office, +1-757-269-4910 x02, nfmorter@dilon.com

Web site: http://www.dilon.com/

-------
Profile: intent